Literature DB >> 10737564

Embryonic smooth muscle myosin heavy chain SMemb is expressed in pressure-overloaded cardiac fibroblasts.

I Shiojima1, M Aikawa, J Suzuki, Y Yazaki, R Nagai.   

Abstract

Left ventricular hypertrophy (LVH) is a secondary adaptation to increased external load. Various qualitative and quantitative changes in myocytes and extracellular components occur during the development of LVH. It has recently been demonstrated that alpha-smooth muscle actin (alpha-SMA)-expressing myofibroblasts appear in the interstitium of the heart subjected to increased workload suggesting that cardiac fibroblasts as well as myocytes alter their phenotype in response to pressure overload. In the present study, to explore the load-induced response and phenotypic modulation of cardiac fibroblasts, the localization of embryonic smooth muscle myosin heavy chain (SMemb) and alpha-SMA in thoracic aorta-constricted rat hearts was investigated by immunohistochemistry, and the morphology of the SMemb-expressing cells was examined by electron microscopy. In addition, to clarify the mechanisms by which SMemb is induced in pressure-overloaded hearts, mRNA expression of SMemb in aorta-constricted rat hearts and in transforming growth factor-beta1 (TGF-beta1)-treated or mechanically-stretched cultured cardiac fibroblasts was investigated. Enhanced staining of SMemb and alpha-SMA was detected in the interstitial spindle-shaped cells in the fibrotic lesions of the pressure-overloaded left ventricles by immunohistochemistry. These cells were demonstrated by electron microscopy to have features specific for activated fibroblasts such as serrated nuclei or prominent rough endoplasmic reticulum. These cells also had characteristic features of myofibroblasts, i.e. irregularly arranged actin filaments and scattered dense bodies. Northern blot analysis revealed increased mRNA levels of SMemb both in aorta-constricted rat hearts and in cultured cardiac fibroblasts stimulated by TGF-beta1 or by mechanical stretch. These results suggest that SMemb may be a molecular marker both for the detection of activated cardiac fibroblasts that may play important roles in the remodeling of pressure-overloaded cardiac interstitium, and for the identification of the regu latory mechanisms that control the phenotypic modulation of cardiac fibroblasts in response to pressure overload.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10737564     DOI: 10.1536/jhj.40.803

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  8 in total

Review 1.  Regulation of smooth muscle phenotype.

Authors:  Ichiro Manabe; Ryozo Nagai
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

Review 2.  The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.

Authors:  Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2019-06-20       Impact factor: 17.367

Review 3.  Myofibroblasts and Fibrosis: Mitochondrial and Metabolic Control of Cellular Differentiation.

Authors:  Andrew A Gibb; Michael P Lazaropoulos; John W Elrod
Journal:  Circ Res       Date:  2020-07-16       Impact factor: 17.367

Review 4.  Myofibroblasts: trust your heart and let fate decide.

Authors:  Jennifer Davis; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2013-11-02       Impact factor: 5.000

5.  Cellular Interplay between Cardiomyocytes and Nonmyocytes in Cardiac Remodeling.

Authors:  Norifumi Takeda; Ichiro Manabe
Journal:  Int J Inflam       Date:  2011-09-18

6.  Role of complement 3a in the synthetic phenotype and angiotensin II-production in vascular smooth muscle cells from spontaneously hypertensive rats.

Authors:  Ying Han; Noboru Fukuda; Takahiro Ueno; Morito Endo; Kazuya Ikeda; Zhou Xueli; Taro Matsumoto; Masayoshi Soma; Koichi Matsumoto
Journal:  Am J Hypertens       Date:  2011-11-17       Impact factor: 2.689

7.  A novel model of reno-cardiac syndrome in the C57BL/ 6 mouse strain.

Authors:  Julius E Kieswich; Jianmin Chen; Samira Alliouachene; Paul W Caton; Kieran McCafferty; Christoph Thiemermann; Muhammad M Yaqoob
Journal:  BMC Nephrol       Date:  2018-12-04       Impact factor: 2.388

8.  Myocardial fibrosis in congenital and pediatric heart disease.

Authors:  Jing Tian; Xinjiang An; Ling Niu
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.